Pharmacological Characterization of GLPG3667, a Tyrosine Kinase 2-Selective Inhibitor, for the Treatment of Inflammatory and Autoimmune Diseases

Inflammation · Published 2026-05-16 · DOI 10.1007/s10753-026-02519-1

Free full text

Authors (17)

Céline Cottereaux, May-Linda Lepage, Isabelle Parent, Maikel Colli, An Van de Water, Emilie Lagoutte, Christelle David, Maarten Van Balen, Adrien Cosson, Roland Blanque, Kenji Shoji, Mia Jans, Laetitia Furio, Steven Van der Plas, Reginald Brys, David Amantini, René Galien

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Cottereaux, C., Lepage, M., Parent, I., et al. (2026). Pharmacological Characterization of GLPG3667, a Tyrosine Kinase 2-Selective Inhibitor, for the Treatment of Inflammatory and Autoimmune Diseases. Inflammation. https://doi.org/10.1007/s10753-026-02519-1

Related articles